Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Computerised tomogram, Herpes zoster
Clinical narrative: Shingles; This is a spontaneous report from a contactable consumer (patient). A 69-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EL3247), via an unspecified route of administration, administered in Arm Left in 23Feb2021 12:20 (at the age of 69years) as 1st dose, single for Covid-19 immunization. Medical history included ongoing rheumatoid arthritis (had this since she was diagnosed she guessed almost 40 years ago, 35-40 years ago), ongoing uterine leiomyoma (onset probably a little over 3 years ago), ongoing bronchotracheomalacia (onset about 2-2.5 years ago), hysterectomy in 1989; bone disorder, thyroid disorder, cardiac disorder, and anemic; all from an unknown date and unknown if ongoing. Family history: cancer (cancer runs in her family). Concomitant medications included zoledronic acid (RECLAST) taken for bone disorder from an unspecified start date and ongoing, estradiol (ESTRADIOL) taken for hysterectomy from 1989 and ongoing, diclofenac sodium (DICLOFENAC SODIUM) taken for rheumatoid arthritis from an unspecified start date and ongoing, prednisone (PREDNISONE) taken for rheumatoid arthritis from an unspecified start date and ongoing, levothyroxine (LEVOTHYROXINE) taken for thyroid disorder from an unspecified start date and ongoing, vitamin D nos (VITAMIN D NOS) taken for bone disorder from an unspecified start date and ongoing, acetylsalicylic acid (ASPIRIN) taken for cardiac disorder from 2018 and ongoing, infliximab (REMICADE) taken for rheumatoid arthritis from 2006 and ongoing, metoprolol (METOPROLOL) taken for cardiac disorder from an unspecified start date and ongoing,  isosorbide mononitrate (ISOSORBIDE MONONITRATE) taken for cardiac disorder from 2018 and ongoing; omeprazole (OMEPRAZOLE), atorvastatin (ATORVASTATIN), celecoxib (CELEXA), and salbutamol sulfate (PROAIR), and Oxygen (not specified); all taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient reported that she had her first PFIZER-BIONTECH COVID-19 VACCINE on 23Feb2021 and was scheduled to have second shot on 16Mar2021, but she has developed the shingles. She had the onset of shingles symptoms around 27Feb2021 which was officially diagnosed as shingles in the emergency room on 01Mar2021. She was not admitted to the hospital for this event. She called to ask if she should or should not get the second dose of Pfizer-BioNTech COVID-19 Vaccine as scheduled for 16Mar2021 relative to this event. She had the symptoms of shingles for a few days before being diagnosed: probably starting on 27Feb2021. She felt her back being kind of itchy and everything. After she took a bath, she told her daughter that her back was burning and itching and asked her to look at the area. Her daughter took a picture of the affected area and said it looked like shingles. On 01Mar2021, the affected area was hurting bad, so they ran her down to the small hospital to the emergency room where she was diagnosed with shingles. She was not admitted to the hospital. They gave her some medication for the shingles including Valtrex, Gabapentin and Hydrocodone-20 tablets of that from the emergency room. The emergency room staff told her to follow-up with her primary care physician which she did with last Friday, 05Mar2021. The affected area of the shingles went all the way around her right side of her back. Results of tests and procedures for investigation of the patient on 15Feb2021: Bloodwork Result: Anemic; CT Scan Result: Nothing found on the scan. The outcome of event was unknown.  No follow-up attempts are possible. No further information is expected. Information on lot number already obtained.